Treatment with 1 and 0.5 mg/mL S-PN resulted in a significant reduction in HMGB1 level in the MRSA-PMN system post-infection, compared to the untreated Model (MRSA-PMN) group (P < 0.05). This evidence concerns the gene HMGB1 and infection.